South Africa launches long-acting HIV injection Lenacapavir
South Africa has officially launched a new, long-acting injectable drug for HIV prevention, marking a significant development in the nation's public health strategy. President Cyril Ramaphosa presided over the rollout event for Lenacapavir at the Lilian Ngoyi Stadium in Secunda, Mpumalanga, on Friday.
Verilumia